Pfizer Inc.
Stability-modulating linkers for use with antibody drug conjugates
Last updated:
Abstract:
The present invention provides stability-modulated antibody-drug conjugates, stability-modulating linker components used to make these stability-modulated antibody-drug conjugates, therapeutic methods using stability-modulated antibody-drug conjugates, and methods of making stability modulating linkers and stability-modulated antibody-drug conjugates.
Status:
Grant
Type:
Utility
Filling date:
14 Aug 2015
Issue date:
6 Apr 2021